AC
MBOT icon

Armistice Capital’s Microbot Medical MBOT Stock Holding History

Armistice Capital’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-300,000
Closed -$492K – 381
2023
Q4 		$492K Buy
+300,000
New +$399K 0.01% 203
2023
Q3 		– Sell
-385,246
Closed -$1.05M – 266
2023
Q2 		$1.05M Sell
385,246
-214,754
-36% -$430K 0.02% 160
2023
Q1 		$1.25M Sell
600,000
-90,000
-13% -$266K 0.02% 132
2022
Q4 		$2.08M Buy
+690,000
New +$2.86M 0.04% 117

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armistice Capital's MBOT Position: Q1 2024 in Review

Armistice Capital sold out of Microbot Medical (MBOT) in Q1 2024, closing a stake of 300,000 shares — an estimated $492K sold.

Armistice Capital first reported a position in MBOT in Q4 2022 and held it in 4 quarters. The position peaked at $2.08M in Q4 2022. 33 funds tracked by Wall St. Rank hold MBOT as of Q1 2024.

  • Armistice Capital reported no remaining Microbot Medical position as of Q1 2024 after selling out during the quarter.
  • Armistice Capital sold 300,000 Microbot Medical shares in Q1 2024, an estimated $492K.
  • Armistice Capital first reported a position in Microbot Medical in Q4 2022 and held it in 4 quarters.
  • Armistice Capital's Microbot Medical position peaked at $2.08M in Q4 2022.
  • 33 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2024.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.